Pharmacokinetic and Bioequivalence Studies of Compound Gestodene Tablet in Chinese Healthy Female Adult Volunteers

FANG Yi,CHAI Dong,WANG Xi-ping,ZHENG Zhuan-jie,CAO Lin,ZHU Zhong-yi,WANG Rui
DOI: https://doi.org/10.3969/j.issn.1009-2501.2007.05.024
2007-01-01
Abstract:AIM: To establish RIA method for determination of gestodene and aethinyloestradiol in blood serum,and investigate the pharmacokinetics and bioequivalence of compound gestodene tablet in Chinese healthy female adult volunteers. METHODS: Twenty-four female healthy volunteers were randomized to receive a single crossover oral dose of compound gestodene reference tablet or domestic tablet. Seven mL venous blood was taken at time 0.25,0.5,0.75,1,1.5,2,4,6,8,12,24,36,48,72 h after administration. The concentrations of gestodene and aethinyloestradiol in blood serum were determined by RIA.The data were managed by DAS Software. RESULTS: The main pharmacokinetic parameters of test and reference compound gestodene tablets were as following: tmax of gestodene were (1.00±0.00) and (1.01±0.12) h; their Cmax were (2756±287) and (2571±387) ng/L; AUC0-t were (23400±4288) and (26275±4609) ng·L-1·h; t1/2 were (13.1±1.6) and (14.5±2.2) h; tmax of aethinyloestradiol were (1.54±0.25) and (1.75±0.25) h; Cmax were (138±13) and (142±16) ng/L; AUC0-t: were (2311±558) and (2266±637) ng·L-1·h; t1/2β were (28±7) and (31±8) h.The relative bioavailabilities of gestodene and aethinyloestradiol of test tablet were 88.97% and 102.87%. CONCLUSION: The assay method is shown to be sensitive and accurate giving reliable results. The test tablet was bioequivalent to the reference tablet.
What problem does this paper attempt to address?